CAI – caris life sciences, inc. (US:NASDAQ)
Stock Stats
News
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center [TheStreet.com]
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients [TheStreet.com]
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
Caris Life Sciences (CAI) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $28.00 price target on the stock.
Form SCHEDULE 13G/A Caris Life Sciences, Filed by: FMR LLC
Form 8-K Caris Life Sciences, For: Apr 01
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Power Luke Thomas
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Denton John Russel
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Spetzler David Baxley
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.